Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Aplasia cutis congenita
ADR ID BADD_A00297
ADR Hierarchy
03      Congenital, familial and genetic disorders
03.05      Skin and subcutaneous tissue disorders congenital
03.05.01      Skin and subcutaneous tissue disorders congenital NEC
03.05.01.011      Aplasia cutis congenita
23      Skin and subcutaneous tissue disorders
23.01      Cornification and dystrophic skin disorders
23.01.04      Skin hyperplasias and hypertrophies
23.01.04.004      Aplasia cutis congenita
Description A group of hereditary disorders involving tissues and structures derived from the embryonic ectoderm. They are characterized by the presence of abnormalities at birth and involvement of both the epidermis and skin appendages. They are generally nonprogressive and diffuse. Various forms exist, including anhidrotic and hidrotic dysplasias, FOCAL DERMAL HYPOPLASIA, and aplasia cutis congenita. [MeSH]
MedDRA Code 10002963
MeSH ID D004476
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Aplasia cutis congenita | Ectodermal Dysplasia | Dysplasia, Ectodermal | Dysplasias, Ectodermal | Ectodermal Dysplasias | Ectodermal Defect, Congenital | Congenital Ectodermal Defect | Congenital Ectodermal Defects | Defects, Congenital Ectodermal | Ectodermal Defects, Congenital | Defect, Congenital Ectodermal | Aplasia Cutis Congenita | Aplasia Cutis Congenita, Nonsyndromic | Hidrotic Ectodermal Dysplasia | Dysplasia, Hidrotic Ectodermal | Dysplasias, Hidrotic Ectodermal | Hidrotic Ectodermal Dysplasias | Hydrotic Ectodermal Dysplasia | Dysplasia, Hydrotic Ectodermal | Dysplasias, Hydrotic Ectodermal | Ectodermal Dysplasia, Hydrotic | Ectodermal Dysplasias, Hydrotic | Hydrotic Ectodermal Dysplasias | Ectodermal Dysplasia, Hidrotic | Clouston Hidrotic Ectodermal Dysplasia | Hidrotic Ectodermal Dysplasia, Autosomal Dominant | Clouston Syndrome | Syndrome, Clouston | Ectodermal Dysplasia 2, Hidrotic | Autosomal Dominant Hidrotic Ectodermal Dysplasia | Clouston's Hidrotic Ectodermal Dysplasia | Clouston's Syndrome | Cloustons Syndrome | Syndrome, Clouston's | Ectodermal Dysplasia, Hidrotic, Autosomal Dominant | Anhidrotic Ectodermal Dysplasia | Anhidrotic Ectodermal Dysplasias | Dysplasia, Anhidrotic Ectodermal | Dysplasias, Anhidrotic Ectodermal | Ectodermal Dysplasia, Anhidrotic | Ectodermal Dysplasias, Anhidrotic | Ectodermal Dysplasia Anhidrotic | Anhidrotic, Ectodermal Dysplasia | Anhidrotics, Ectodermal Dysplasia | Dysplasia Anhidrotic, Ectodermal | Dysplasia Anhidrotics, Ectodermal | Ectodermal Dysplasia, Anhydrotic | Anhydrotic Ectodermal Dysplasia | Anhydrotic Ectodermal Dysplasias | Dysplasia, Anhydrotic Ectodermal | Dysplasias, Anhydrotic Ectodermal | Ectodermal Dysplasias, Anhydrotic
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00129Amoxicillin0.000005%
BADD_D00356Carbamazepine0.000220%
BADD_D00974Fragmin--
BADD_D01243Lamotrigine0.000101%
BADD_D01414Methimazole0.000424%
BADD_D01627Oseltamivir0.000038%
BADD_D01869Propylthiouracil0.002851%
The 1th Page    1    Total 1 Pages